TreeWAS – Variant ID: rs3805663

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T40.4 Other synthetic narcotics	0.000	0.925	0.075
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.926	0.074
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.931	0.069
T40.2 Other opioids	0.000	0.931	0.069
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.937	0.063
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.939	0.061
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.941	0.059
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.942	0.058
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.942	0.058
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.942	0.058
T36 Poisoning by systemic antibiotics	0.000	0.945	0.055
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.945	0.055
T40.1 Heroin	0.000	0.946	0.054
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.946	0.054
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.947	0.053
T40.8 Lysergide [LSD]	0.000	0.947	0.053
T40.7 Cannabis (derivatives)	0.000	0.947	0.053
T40.3 Methadone	0.000	0.947	0.053
T40.0 Opium	0.000	0.947	0.053
T40.6 Other and unspecified narcotics	0.000	0.947	0.053
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.948	0.052
T43.2 Other and unspecified antidepressants	0.000	0.949	0.051
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.949	0.051
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.949	0.051
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.949	0.050
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.950	0.050
T40.5 Cocaine	0.000	0.950	0.050
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.950	0.050
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.950	0.050
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.950	0.050
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.951	0.049
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.952	0.048
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.953	0.047
T42.0 Hydantoin derivatives	0.000	0.953	0.047
T36.0 Penicillins	0.000	0.954	0.046
T45.5 Anticoagulants	0.000	0.955	0.045
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.955	0.045
T46.7 Peripheral vasodilators	0.000	0.955	0.045
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.955	0.045
T45.0 Antiallergic and antiemetic drugs	0.000	0.955	0.045
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.045	0.955	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.955	0.045
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.955	0.045
D47.3 Essential (haemorrhagic) thrombocythaemia	0.044	0.956	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.956	0.044
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.956	0.044
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.956	0.044
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.956	0.044
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.956	0.044
T44.0 Anticholinesterase agents	0.000	0.956	0.044
D47.2 Monoclonal gammopathy	0.044	0.956	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.957	0.043
D37-D48 Neoplasms of uncertain or unknown behaviour	0.043	0.957	0.000
T45.2 Vitamins, not elsewhere classified	0.000	0.957	0.043
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.958	0.042
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.958	0.042
T43.9 Psychotropic drug, unspecified	0.000	0.958	0.042
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.958	0.042
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.958	0.042
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.042	0.958	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.958	0.042
T42.3 Barbiturates	0.000	0.958	0.042
T42.2 Succinimides and oxazolidinediones	0.000	0.958	0.042
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.958	0.042
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.958	0.042
T46.1 Calcium-channel blockers	0.000	0.958	0.042
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.958	0.042
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.958	0.041
T45.8 Other primarily systemic and haematological agents	0.000	0.958	0.041
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.958	0.041
T45.6 Fibrinolysis-affecting drugs	0.000	0.958	0.041
T45.4 Iron and its compounds	0.000	0.958	0.041
T45.3 Enzymes, not elsewhere classified	0.000	0.958	0.041
D46 Myelodysplastic syndromes	0.041	0.959	0.000
D38.1 Trachea, bronchus and lung	0.041	0.959	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.959	0.041
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.959	0.041
T36.3 Macrolides	0.000	0.960	0.040
T36.9 Systemic antibiotic, unspecified	0.000	0.960	0.040
T36.8 Other systemic antibiotics	0.000	0.960	0.040
T36.7 Antifungal antibiotics, systemically used	0.000	0.960	0.040
T36.6 Rifamycins	0.000	0.960	0.040
T36.5 Aminoglycosides	0.000	0.960	0.040
T36.4 Tetracyclines	0.000	0.960	0.040
T36.2 Chloramphenicol group	0.000	0.960	0.040
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.960	0.040
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.960	0.039
T43.6 Psychostimulants with abuse potential	0.000	0.962	0.038
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.038	0.962	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.962	0.038
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.037	0.963	0.000
D38.0 Larynx	0.037	0.963	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.963	0.037
T42.1 Iminostilbenes	0.000	0.963	0.037
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.963	0.037
T37.5 Antiviral drugs	0.000	0.963	0.037
T37.4 Anthelminthics	0.000	0.963	0.037
T37.3 Other antiprotozoal drugs	0.000	0.963	0.037
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.963	0.037
T37.1 Antimycobacterial drugs	0.000	0.963	0.037
T37.0 Sulphonamides	0.000	0.963	0.037
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.964	0.036
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.964	0.036
T47.7 Emetics	0.000	0.964	0.036
T47.5 Digestants	0.000	0.964	0.036
T47.3 Saline and osmotic laxatives	0.000	0.964	0.036
T47.0 Histamine H(2)-receptor antagonists	0.000	0.964	0.036
T38.9 Other and unspecified hormone antagonists	0.000	0.964	0.036
T38.7 Androgens and anabolic congeners	0.000	0.964	0.036
T38.5 Other oestrogens and progestogens	0.000	0.964	0.036
T38.4 Oral contraceptives	0.000	0.964	0.036
T38.2 Antithyroid drugs	0.000	0.964	0.036
T38.0 Glucocorticoids and synthetic analogues	0.000	0.964	0.036
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.036	0.964	0.000
D46.5 Refractory anaemia with multi-lineage dysplasia	0.036	0.964	0.000
T41.5 Therapeutic gases	0.000	0.964	0.036
T41.4 Anaesthetic, unspecified	0.000	0.964	0.036
T41.3 Local anaesthetics	0.000	0.964	0.036
T41.2 Other and unspecified general anaesthetics	0.000	0.964	0.036
T41.1 Intravenous anaesthetics	0.000	0.964	0.036
T41.0 Inhaled anaesthetics	0.000	0.964	0.036
T49.9 Topical agent, unspecified	0.000	0.964	0.036
T49.8 Other topical agents	0.000	0.964	0.036
T49.7 Dental drugs, topically applied	0.000	0.964	0.036
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.964	0.036
T49.5 Ophthalmological drugs and preparations	0.000	0.964	0.036
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.964	0.036
T49.3 Emollients, demulcents and protectants	0.000	0.964	0.036
T49.2 Local astringents and local detergents	0.000	0.964	0.036
T49.1 Antipruritics	0.000	0.964	0.036
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.964	0.036
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.965	0.035
T48.5 Anti-common-cold drugs	0.000	0.965	0.035
T48.4 Expectorants	0.000	0.965	0.035
T48.3 Antitussives	0.000	0.965	0.035
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.965	0.035
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.965	0.035
T48.0 Oxytocic drugs	0.000	0.965	0.035
T47.4 Other laxatives	0.000	0.965	0.035
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.965	0.035
D43.2 Brain, unspecified	0.035	0.965	0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.034	0.966	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.966	0.034
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.966	0.034
D46.1 Refractory anaemia with sideroblasts	0.034	0.966	0.000
T47.2 Stimulant laxatives	0.000	0.966	0.034
M19.93 Arthrosis, unspecified (Forearm)	0.000	0.966	0.034
D46.4 Refractory anaemia, unspecified	0.034	0.966	0.000
D47.4 Osteomyelofibrosis	0.033	0.967	0.000
T47.6 Antidiarrhoeal drugs	0.000	0.967	0.033
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.033	0.967	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.033	0.967	0.000
D44.1 Adrenal gland	0.032	0.967	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.032	0.968	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.968	0.032
D44.0 Thyroid gland	0.032	0.968	0.000
D48.7 Other specified sites	0.032	0.968	0.000
D46.2 Refractory anaemia with excess of blasts	0.031	0.969	0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.031	0.969	0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.031	0.969	0.000
D44.3 Pituitary gland	0.031	0.969	0.000
T50.8 Diagnostic agents	0.000	0.969	0.031
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.030	0.970	0.000
D38.6 Respiratory organ, unspecified	0.030	0.970	0.000
D38.4 Thymus	0.030	0.970	0.000
D38.3 Mediastinum	0.030	0.970	0.000
D38.2 Pleura	0.030	0.970	0.000
D48.6 Breast	0.030	0.970	0.000
T42.4 Benzodiazepines	0.000	0.970	0.030
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.030	0.970	0.000
D46.3 Refractory anaemia with excess of blasts with transformation	0.030	0.970	0.000
D46.0 Refractory anaemia without sideroblasts, so stated	0.030	0.970	0.000
T50.4 Drugs affecting uric acid metabolism	0.000	0.970	0.030
D46.7 Other myelodysplastic syndromes	0.029	0.970	0.000
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.029	0.970	0.000
T50.7 Analeptics and opioid receptor antagonists	0.000	0.971	0.029
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.971	0.029
T50.5 Appetite depressants	0.000	0.971	0.029
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.971	0.029
T50.1 Loop [high-ceiling] diuretics	0.000	0.971	0.029
T50.0 Mineralocorticoids and their antagonists	0.000	0.971	0.029
D47.1 Chronic myeloproliferative disease	0.029	0.971	0.000
D44.4 Craniopharyngeal duct	0.029	0.971	0.000
D43.0 Brain, supratentorial	0.028	0.972	0.000
D43.1 Brain, infratentorial	0.027	0.972	0.000
D48.1 Connective and other soft tissue	0.028	0.972	0.000
D43.9 Central nervous system, unspecified	0.027	0.972	0.000
D43.7 Other parts of central nervous system	0.027	0.972	0.000
D43.3 Cranial nerves	0.027	0.972	0.000
D43.4 Spinal cord	0.027	0.973	0.000
D48.0 Bone and articular cartilage	0.027	0.973	0.000
D44.5 Pineal gland	0.027	0.973	0.000
D44.2 Parathyroid gland	0.027	0.973	0.000
D48.2 Peripheral nerves and autonomic nervous system	0.027	0.973	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.973	0.027
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.973	0.027
D48.3 Retroperitoneum	0.026	0.974	0.000
D44.9 Endocrine gland, unspecified	0.026	0.974	0.000
D44.8 Pluriglandular involvement	0.025	0.975	0.000
D48.4 Peritoneum	0.025	0.975	0.000
D40.0 Prostate	0.024	0.976	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.976	0.024
D44.6 Carotid body	0.024	0.976	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.977	0.023
D38.5 Other respiratory organs	0.023	0.977	0.000
D42.9 Meninges, unspecified	0.022	0.977	0.000
D42.1 Spinal meninges	0.022	0.977	0.000
D42.0 Cerebral meninges	0.022	0.977	0.000
D40.7 Other male genital organs	0.022	0.978	0.000
D45 Polycythaemia vera	0.022	0.978	0.000
D40.9 Male genital organ, unspecified	0.022	0.978	0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.022	0.978	0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.021	0.979	0.000
D37.7 Other digestive organs	0.020	0.980	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.980	0.020
D44.7 Aortic body and other paraganglia	0.019	0.981	0.000
T39.4 Antirheumatics, not elsewhere classified	0.000	0.981	0.019
T39.2 Pyrazolone derivatives	0.000	0.981	0.019
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.981	0.019
D39.7 Other female genital organs	0.018	0.981	0.000
D37.5 Rectum	0.018	0.982	0.000
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.018	0.982	0.000
D40.1 Testis	0.018	0.982	0.000
T39.1 4-Aminophenol derivatives	0.000	0.983	0.017
D37.3 Appendix	0.017	0.983	0.000
D39.9 Female genital organ, unspecified	0.016	0.984	0.000
D39.2 Placenta	0.016	0.984	0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.015	0.985	0.000
D37.0 Lip, oral cavity and pharynx	0.014	0.986	0.000
T39.0 Salicylates	0.000	0.986	0.014
I12.0 Hypertensive renal disease with renal failure	0.013	0.987	0.000
D37.2 Small intestine	0.013	0.987	0.000
D37.1 Stomach	0.012	0.987	0.000
D39.0 Uterus	0.012	0.988	0.001
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.988	0.012
D41.2 Ureter	0.011	0.989	0.000
D41.9 Urinary organ, unspecified	0.011	0.989	0.000
D41.7 Other urinary organs	0.011	0.989	0.000
D41.3 Urethra	0.011	0.989	0.000
D41.1 Renal pelvis	0.011	0.989	0.000
T51.0 Ethanol	0.000	0.990	0.010
Z49.1 Extracorporeal dialysis	0.010	0.990	0.000
D37.9 Digestive organ, unspecified	0.009	0.990	0.000
D48.5 Skin	0.008	0.991	0.000
S32.40 Fracture of acetabulum (closed)	0.000	0.992	0.008
Z49.0 Preparatory care for dialysis	0.007	0.993	0.000
Z49 Care involving dialysis	0.007	0.993	0.000
D37.6 Liver, gallbladder and bile ducts	0.007	0.993	0.001
D37.4 Colon	0.007	0.993	0.000
I12 Hypertensive renal disease	0.007	0.993	0.000
G71.0 Muscular dystrophy	0.007	0.993	0.000
Q50.4 Embryonic cyst of Fallopian tube	0.000	0.993	0.007
D41.0 Kidney	0.006	0.994	0.000
D39.1 Ovary	0.005	0.994	0.001
Z49.2 Other dialysis	0.006	0.994	0.000
K40.9 Unilateral or unspecified inguinal hernia, without obstruction or gangrene	0.000	0.995	0.005
H21.8 Other specified disorders of iris and ciliary body	0.000	0.995	0.005
K80.4 Calculus of bile duct with cholecystitis	0.005	0.995	0.000
G71 Primary disorders of muscles	0.005	0.995	0.000
I12.9 Hypertensive renal disease without renal failure	0.005	0.995	0.000
D41.4 Bladder	0.005	0.995	0.000
C45.9 Mesothelioma, unspecified	0.000	0.995	0.005
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.005	0.995	0.000
D17.6 Benign lipomatous neoplasm of spermatic cord	0.000	0.996	0.004
C49 Malignant neoplasm of other connective and soft tissue	0.000	0.996	0.004
S82.00 Fracture of patella (closed)	0.000	0.996	0.004
C49.1 Connective and soft tissue of upper limb, including shoulder	0.000	0.996	0.004
H21 Other disorders of iris and ciliary body	0.000	0.996	0.004
G71.1 Myotonic disorders	0.004	0.996	0.000
C45 Mesothelioma	0.000	0.996	0.004
C49.3 Connective and soft tissue of thorax	0.000	0.996	0.004
I15.1 Hypertension secondary to other renal disorders	0.004	0.996	0.000
C49.9 Connective and soft tissue, unspecified	0.000	0.996	0.004
T51 Toxic effect of alcohol	0.000	0.996	0.004
V48.4 Person injured while boarding or alighting	0.000	0.996	0.004
F06.7 Mild cognitive disorder	0.000	0.996	0.004
G71.9 Primary disorder of muscle, unspecified	0.004	0.996	0.000
G71.8 Other primary disorders of muscles	0.004	0.996	0.000
G71.2 Congenital myopathies	0.004	0.996	0.000
H21.9 Disorder of iris and ciliary body, unspecified	0.000	0.996	0.004
I15 Secondary hypertension	0.004	0.996	0.000
C49.6 Connective and soft tissue of trunk, unspecified	0.000	0.996	0.004
S32.4 Fracture of acetabulum	0.000	0.996	0.004
G70-G73 Diseases of myoneural junction and muscle	0.004	0.996	0.000
C45.0 Mesothelioma of pleura	0.000	0.996	0.004
H21.0 Hyphaema	0.000	0.996	0.004
G72 Other myopathies	0.004	0.996	0.000
H21.5 Other adhesions and disruptions of iris and ciliary body	0.000	0.996	0.004
C49.5 Connective and soft tissue of pelvis	0.000	0.996	0.004
G71.3 Mitochondrial myopathy, not elsewhere classified	0.003	0.996	0.000
G72.9 Myopathy, unspecified	0.003	0.996	0.000
C69.3 Choroid	0.003	0.996	0.000
C49.2 Connective and soft tissue of lower limb, including hip	0.000	0.997	0.003
H21.2 Degeneration of iris and ciliary body	0.000	0.997	0.003
Y79.2 Prosthetic and other implants, materials and accessory devices	0.003	0.997	0.000
C49.8 Overlapping lesion of connective and soft tissue	0.000	0.997	0.003
I15.9 Seconday hypertension, unspecified	0.003	0.997	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.000	0.997	0.003
I15.8 Other secondary hypertension	0.003	0.997	0.000
H80.9 Otosclerosis, unspecified	0.000	0.997	0.003
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.000	0.997	0.003
G73 Disorders of myoneural junction and muscle in diseases classified elsewhere	0.003	0.997	0.000
H21.3 Cyst of iris, ciliary body and anterior chamber	0.000	0.997	0.003
G72.4 Inflammatory myopathy, not elsewhere classified	0.003	0.997	0.000
H33.5 Other retinal detachments	0.000	0.997	0.003
O64.1 Obstructed labour due to breech presentation	0.000	0.997	0.003
Z01.8 Other specified special examinations	0.000	0.997	0.003
H21.4 Pupillary membranes	0.000	0.997	0.003
C45.2 Mesothelioma of pericardium	0.000	0.997	0.003
C45.1 Mesothelioma of peritoneum	0.000	0.997	0.003
C71.1 Frontal lobe	0.003	0.997	0.000
T51.8 Other alcohols	0.000	0.997	0.003
T51.3 Fusel oil	0.000	0.997	0.003
T51.2 2-Propanol	0.000	0.997	0.003
T51.1 Methanol	0.000	0.997	0.003
I15.0 Renovascular hypertension	0.003	0.997	0.000
G70 Myasthenia gravis and other myoneural disorders	0.003	0.997	0.000
M25.50 Pain in joint (Multiple sites)	0.000	0.997	0.003
S32.41 Fracture of acetabulum (open)	0.000	0.997	0.003
I15.2 Hypertension secondary to endocrine disorders	0.003	0.997	0.000
C49.0 Connective and soft tissue of head, face and neck	0.000	0.997	0.003
R30.9 Painful micturition, unspecified	0.000	0.997	0.003
I10-I15 Hypertensive diseases	0.003	0.997	0.000
G72.8 Other specified myopathies	0.003	0.997	0.000
G72.3 Periodic paralysis	0.003	0.997	0.000
G72.2 Myopathy due to other toxic agents	0.003	0.997	0.000
G72.1 Alcoholic myopathy	0.003	0.997	0.000
G73.7 Myopathy other diseases classified elsewhere	0.003	0.997	0.000
C49.4 Connective and soft tissue of abdomen	0.000	0.997	0.003
G72.0 Drug-induced myopathy	0.003	0.997	0.000
Z11.2 Special screening examination for other bacterial diseases	0.000	0.997	0.003
C45.7 Mesothelioma of other sites	0.000	0.997	0.003
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.000	0.997	0.003
N92.1 Excessive and frequent menstruation with irregular cycle	0.000	0.997	0.003
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.003	0.997	0.000
J94.8 Other specified pleural conditions	0.003	0.997	0.000
G70.0 Myasthenia gravis	0.003	0.997	0.000
H21.1 Other vascular disorders of iris and ciliary body	0.000	0.997	0.003
Q50.5 Embryonic cyst of broad ligament	0.000	0.997	0.003
T90.9 Sequelae of unspecified injury of head	0.000	0.997	0.003
H33.2 Serous retinal detachment	0.000	0.997	0.003
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.000	0.997	0.003
C46 Kaposi's sarcoma	0.000	0.997	0.003
S60.8 Other superficial injuries of wrist and hand	0.003	0.997	0.000
Q50.6 Other congenital malformatons of Fallopian tube and broad ligament	0.000	0.997	0.002
Q50.3 Other congenital malformations of ovary	0.000	0.997	0.002
Q50.2 Congenital torsion of ovary	0.000	0.997	0.002
Q50.1 Developmental ovarian cyst	0.000	0.997	0.002
Q50.0 Congenital absence of ovary	0.000	0.997	0.002
C69 Malignant neoplasm of eye and adnexa	0.003	0.997	0.000
G73.6 Myopathy in metabolic diseases	0.002	0.997	0.000
G73.5 Myopathy in endocrine diseases	0.002	0.997	0.000
G73.4 Myopathy in infectious and parasitic diseases classified elsewhere	0.002	0.997	0.000
G73.3 Myasthenic syndromes in other diseases classified elsewhere	0.002	0.997	0.000
G73.2 Other myasthenic syndromes in neoplastic disease	0.002	0.997	0.000
G73.1 Eaton-Lambert syndrome	0.002	0.997	0.000
G73.0 Myasthenic syndromes in endocrine diseases	0.002	0.997	0.000
T90.5 Sequelae of intracranial injury	0.000	0.997	0.003
S80.8 Other superficial injuries of lower leg	0.003	0.997	0.000
F32.0 Mild depressive episode	0.000	0.997	0.003
D18.0 Haemangioma, any site	0.003	0.997	0.000
U80.0 Penicillin resistant agent	0.000	0.997	0.003
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.000	0.997	0.002
G70.8 Other specified myoneural disorders	0.002	0.998	0.000
G70.2 Congenital and developmental myasthenia	0.002	0.998	0.000
G70.1 Toxic myoneural disorders	0.002	0.998	0.000
S00.2 Other superficial injuries of eyelid and periocular area	0.000	0.998	0.002
L27.0 Generalised skin eruption due to drugs and medicaments	0.002	0.998	0.000
H90.3 Sensorineural hearing loss, bilateral	0.002	0.998	0.000
H33.4 Traction detachment of retina	0.000	0.998	0.002
I13 Hypertensive heart and renal disease	0.002	0.998	0.000
C71 Malignant neoplasm of brain	0.002	0.998	0.000
Y79 Orthopaedic devices associated with adverse incidents	0.002	0.998	0.000
E07.9 Disorder of thyroid, unspecified	0.000	0.998	0.002
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.000	0.998	0.002
C71.3 Parietal lobe	0.002	0.998	0.000
L81.9 Disorder of pigmentation, unspecified	0.000	0.998	0.002
C69.6 Orbit	0.002	0.998	0.000
Y79.3 Surgical instruments, materials and devices (including sutures)	0.002	0.998	0.000
H33 Retinal detachments and breaks	0.000	0.998	0.002
V48 Car occupant injured in noncollision transport accident	0.000	0.998	0.002
C46.9 Kaposi's sarcoma, unspecified	0.000	0.998	0.002
C46.8 Kaposi's sarcoma of multiple organs	0.000	0.998	0.002
C46.7 Kaposi's sarcoma of other sites	0.000	0.998	0.002
C46.3 Kaposi's sarcoma of lymph nodes	0.000	0.998	0.002
C46.2 Kaposi's sarcoma of palate	0.000	0.998	0.002
C46.1 Kaposi's sarcoma of soft tissue	0.000	0.998	0.002
C46.0 Kaposi's sarcoma of skin	0.000	0.998	0.002
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.000	0.998	0.002
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.000	0.998	0.002
C47.6 Peripheral nerves of trunk, unspecified	0.000	0.998	0.002
C47.5 Peripheral nerves of pelvis	0.000	0.998	0.002
C47.4 Peripheral nerves of abdomen	0.000	0.998	0.002
C47.3 Peripheral nerves of thorax	0.000	0.998	0.002
C47.2 Peripheral nerves of lower limb, including hip	0.000	0.998	0.002
C47.1 Peripheral nerves of upper limb, including shoulder	0.000	0.998	0.002
C47.0 Peripheral nerves of head, face and neck	0.000	0.998	0.002
C69.8 Overlapping lesion of eye and adnexa	0.002	0.998	0.000
C69.5 Lachrymal gland and duct	0.002	0.998	0.000
C69.4 Ciliary body	0.002	0.998	0.000
C69.2 Retina	0.002	0.998	0.000
C69.1 Cornea	0.002	0.998	0.000
G70.9 Myoneural disorder, unspecified	0.002	0.998	0.000
H72.8 Other perforations of tympanic membrane	0.002	0.998	0.000
T51.9 Alcohol, unspecified	0.000	0.998	0.002
A09.0 Other and unspecified gastroenteritis and colitis of infectious origin	0.002	0.998	0.000
C71.7 Brain stem	0.002	0.998	0.000
F32.2 Severe depressive episode without psychotic symptoms	0.000	0.998	0.002
T90.1 Sequelae of open wound of head	0.000	0.998	0.002
M89.9 Disorder of bone, unspecified	0.002	0.998	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.002	0.998	0.000
C48.0 Retroperitoneum	0.000	0.998	0.002
C71.0 Cerebrum, except lobes and ventricles	0.002	0.998	0.000
S00.1 Contusion of eyelid and periocular area	0.000	0.998	0.002
C69.9 Eye, unspecified	0.002	0.998	0.000
L81.2 Freckles	0.000	0.998	0.002
M89.93 Disorder of bone, unspecified (Forearm)	0.002	0.998	0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.000	0.998	0.002
C69.0 Conjunctiva	0.002	0.998	0.000
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure	0.002	0.998	0.000
I13.1 Hypertensive heart and renal disease with renal failure	0.002	0.998	0.000
I13.0 Hypertensive heart and renal disease with (congestive) heart failure	0.002	0.998	0.000
Y79.8 Miscellaneous devices, not elsewhere classified	0.002	0.998	0.000
Y79.1 Therapeutic (nonsurgical) and rehabilitative devices	0.002	0.998	0.000
Y79.0 Diagnostic and monitoring devices	0.002	0.998	0.000
C70 Malignant neoplasm of meninges	0.002	0.998	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.998	0.002
C70.0 Cerebral meninges	0.002	0.998	0.000
C71.6 Cerebellum	0.002	0.998	0.000
C71.5 Cerebral ventricle	0.002	0.998	0.000
I13.9 Hypertensive heart and renal disease, unspecified	0.002	0.998	0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.000	0.998	0.002
M89.96 Disorder of bone, unspecified (Lower leg)	0.002	0.998	0.000
C48.1 Specified parts of peritoneum	0.000	0.998	0.002
I11 Hypertensive heart disease	0.002	0.998	0.000
V48.5 Driver injured in traffic accident	0.000	0.998	0.002
V48.9 Unspecified car occupant injured in traffic accident	0.000	0.998	0.002
V48.7 Person on outside of vehicle injured in traffic accident	0.000	0.998	0.002
V48.6 Passenger injured in traffic accident	0.000	0.998	0.002
V48.3 Unspecified car occupant injured in nontraffic accident	0.000	0.998	0.002
V48.2 Person on outside of vehicle injured in nontraffic accident	0.000	0.998	0.002
V48.1 Passenger injured in nontraffic accident	0.000	0.998	0.002
I60 Subarachnoid haemorrhage	0.000	0.998	0.002
C71.8 Overlapping lesion of brain	0.002	0.998	0.000
L81.4 Other melanin hyperpigmentation	0.000	0.998	0.002
O24.0 Pre-existing diabetes mellitus, insulin-dependent	0.000	0.998	0.002
Z13.1 Special screening examination for diabetes mellitus	0.002	0.998	0.000
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.000	0.998	0.002
V48.0 Driver injured in nontraffic accident	0.000	0.998	0.002
T90 Sequelae of injuries of head	0.000	0.998	0.002
F32.1 Moderate depressive episode	0.000	0.998	0.002
M16.9 Coxarthrosis, unspecified	0.002	0.998	0.000
H33.0 Retinal detachment with retinal break	0.000	0.998	0.002
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
S12.70 Multiple fractures of cervical spine (closed)	0.000	0.998	0.002
S05.0 Injury of conjunctiva and corneal abrasion without mention of foreign body	0.000	0.998	0.002
M89.91 Disorder of bone, unspecified (Shoulder region)	0.002	0.998	0.000
H33.1 Retinoschisis and retinal cysts	0.000	0.998	0.002
M89.92 Disorder of bone, unspecified (Upper arm)	0.002	0.998	0.000
O24.4 Diabetes mellitus arising in pregnancy	0.000	0.998	0.002
R52.2 Other chronic pain	0.002	0.998	0.000
M89.99 Disorder of bone, unspecified (Site unspecified)	0.002	0.998	0.000
M89.98 Disorder of bone, unspecified (Other)	0.002	0.998	0.000
M89.90 Disorder of bone, unspecified (Multiple sites)	0.002	0.998	0.000
I11.0 Hypertensive heart disease with (congestive) heart failure	0.002	0.998	0.000
L81 Other disorders of pigmentation	0.000	0.998	0.002
C70.9 Meninges, unspecified	0.002	0.998	0.000
C70.1 Spinal meninges	0.002	0.998	0.000
C71.4 Occipital lobe	0.002	0.998	0.000
S82.0 Fracture of patella	0.000	0.998	0.002
T93.9 Sequelae of unspecified injury of lower limb	0.000	0.998	0.002
T68 Hypothermia	0.002	0.998	0.000
Z99.1 Dependence on respirator	0.002	0.998	0.000
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
S00.5 Superficial injury of lip and oral cavity	0.000	0.998	0.002
M89.94 Disorder of bone, unspecified (Hand)	0.002	0.998	0.000
B16.9 Acute hepatitis B without delta-agent and without hepatic coma	0.000	0.998	0.002
V48.59 Car occupant injured in noncollision transport accident; driver injured in traffic accident; during unspecified activity	0.000	0.998	0.001
I60.5 Subarachnoid haemorrhage from vertebral artery	0.000	0.998	0.002
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.001	0.998	0.000
S00 Superficial injury of head	0.000	0.998	0.002
N18.8 Other chronic renal failure	0.002	0.998	0.000
N92.4 Excessive bleeding in the premenopausal period	0.000	0.998	0.002
Z12.6 Special screening examination for neoplasm of bladder	0.002	0.998	0.000
D86.8 Sarcoidosis of other and combined sites	0.002	0.998	0.000
J15.1 Pneumonia due to Pseudomonas	0.000	0.998	0.002
U80 Agent resistant to penicillin and related antibiotics	0.000	0.998	0.002
S06.30 Focal brain injury (without open intracranial wound)	0.000	0.998	0.002
R93.4 Abnormal findings on diagnostic imaging of urinary organs	0.002	0.998	0.000
T90.0 Sequelae of superficial injury of head	0.000	0.998	0.001
Z41.1 Other plastic surgery for unacceptable cosmetic appearance	0.002	0.998	0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.000	0.998	0.002
M25.31 Other instability of joint (Shoulder region)	0.000	0.998	0.002
C71.9 Brain, unspecified	0.002	0.998	0.000
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.000	0.998	0.002
S00.4 Superficial injury of ear	0.000	0.998	0.001
H80 Otosclerosis	0.000	0.998	0.002
L81.7 Pigmented purpuric dermatosis	0.000	0.998	0.001
L81.6 Other disorders of diminished melanin formation	0.000	0.998	0.001
L81.5 Leukoderma, not elsewhere classified	0.000	0.998	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations